Press release
Globle Structured Cabling Market to Grow 2X Through 2031
Award-winning consulting firm Fact.MR’s report on the global human umbilical vein endothelial cells (HUVEC) market forecasts a healthy growth trajectory for the 2021-2031 forecast period. According to the study, rapid advancements in biotechnology and genetic engineering are opening up new growth avenues for advanced disease treatment, particularly across areas such as oncology.As per data published by GLOBOCAN, global cancer burden rose to 19.3 million cases, while associated fatalities increased to 10 million by 2020. Amongst all the cancers, breast cancer accounts for nearly a quarter of the total cases diagnosed every year. Hence, healthcare providers are incorporating highly advanced therapeutic approaches, thereby widening the growth prospects for human umbilical vein endothelial cells.
Manufacturers are directing bulk of their investments across key regions such as China, India, and other countries in Asia Pacific. Over the years, these countries have witnessed unprecedented expansion of their existing healthcare infrastructure. This is majorly attributed to the presence of a huge population base, necessitating delivery of advanced healthcare for various chronic and infectious diseases.
For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=1030
Key Takeaways from Market Study
• By type, pooled donor-derived HUVECs are expected to experience elevated sales through 2031
• Oncology to emerge as a highly promising application area for HUVEC-based treatment
• The U.S. to generate multiple revenue streams for the market, across CVD treatment, oncology, and angiogenesis
• Extensive development of biotechnology and cell culture studies driving demand across India
For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=S&rep_id=1030
Competitive Landscape
Prominent HUVEC providers as profiled by Fact.MR include Lonza Group AG, PromoCell- Human Centered Science, Merck & Co. KGaA, Thermo Fisher Scientific, Lifeline, and Corning Inc. Due to the presence of such a handful of service providers, the market appears highly consolidated.
In May 2021, Merck & Co. announced 40 abstracts, seven oral presentations and seven poster discussions from company and investigator sponsored studies and external collaborations for its oncology treatment furtherance, an initiative which will likely provide tailwinds to its HUVEC portfolio.
In January 2021, PromoCell received the EXCiPACTTM certification scheme for pharmaceutical excipients to Good Manufacturing Practice (GMP) standards, which implied that the company can provide tailor-made cell culture media and reagents based on each client’s end user requirements.
For in-depth competitive analysis, buy now –
https://www.factmr.com/checkout/1030
More ICT Market Reports from Fact.MR
Managed Network Services Market- Fact.MR envisages that the demand for managed network services is projected to expand at a stellar pace growing at a value CAGR in the range of 8% to 9% throughout the period of forecast, 2018-2028. The sales of managed network services during the said timeline are expected to surpass US$ 120 Bn by end of 2028.
Big Data Analytics in Healthcare Market- According to study, global big data analytics in healthcare market is expected to register an outstanding expansion during the forecast period (2017-2026). Revenues from global sales of big data analytics in healthcare sector are estimated to exceed US$ 45,000 Mn by 2026-end.
Clinical Trial Management Systems Market- Web-based clinical trial management systems continue to be the preferred mode of deployment for pharmaceutical and biotechnology companies, finds a new study by Fact.MR. Study also projects that web-based clinical trial management systems will remain pervasive in the clinical trial management systems market through 2028, gaining an impressive US$ 116 Mn in incremental opportunity in a decade.
For comprehensive insights on this market adoption, ask an analyst here – https://www.factmr.com/connectus/sample?flag=S&rep_id=1030
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Globle Structured Cabling Market to Grow 2X Through 2031 here
News-ID: 2297968 • Views: …
More Releases from Fact.MR
Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB L …
Digital Twin Market is valued at USD 5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 34.3%, reaching USD 95 billion by 2033. This explosive growth is driven by the increasing adoption of digital twins across industries to optimize operations, reduce costs, and enhance decision-making through virtual replicas of physical assets. Digital twins integrate IoT, AI, and data analytics to simulate real-world…
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 …
The global hemato oncology testing market is valued at USD 4.33 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 18.5%, reaching USD 23.64 billion by 2033. This rapid growth is driven by the increasing prevalence of blood-related cancers, such as lymphoma and leukemia, and advancements in diagnostic technologies like next-generation sequencing (NGS) and polymerase chain reaction (PCR). Hemato oncology testing plays a…
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 203 …
Osseointegration Implants Market is poised for robust growth, with its valuation projected to rise from USD 3.17 billion in 2025 to USD 6.85 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8%. This expansion is driven by the increasing prevalence of orthopedic and dental disorders, such as osteoarthritis, rheumatoid arthritis, and edentulism, which necessitate advanced implant solutions. Osseointegration implants, which fuse directly with bone to provide stable…
Fibrin Sealants Market is Anticipated to Reach USD 1.92 Billion by 2033 | Fact.M …
The global fibrin sealants market is valued at USD 976.5 million in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 7%, reaching USD 1.92 billion by 2033. This growth is driven by the increasing prevalence of surgical procedures requiring effective hemostasis and tissue sealing, particularly in cardiovascular, orthopedic, and general surgeries. Fibrin sealants, derived from human plasma proteins, mimic the body's natural clotting process,…
More Releases for HUVEC
Human Umbilical Vein Endothelial Cells (HUVEC) Market Is Set To Register A CAGR …
The market for Human Umbilical Vein Endothelial Cells (HUVEC) is a vital segment within the field of cell culture and regenerative medicine. HUVECs, as primary cells, are widely used in various biomedical and pharmaceutical research applications, making them integral in understanding vascular biology, angiogenesis, and drug development. This market overview will provide insights into the current state of the HUVEC market, recent developments, and key factors influencing its growth.
Growth of…
Human Umbilical Vein Endothelial Cells (HUVEC) Market 2028- Analysis And In-Dept …
QY Research has recently published a new report, titled Global Human Umbilical Vein Endothelial Cells (HUVEC) Market Research Report 2022. The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Human Umbilical Vein Endothelial Cells (HUVEC) market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the…
Human Umbilical Vein Endothelial Cells (HUVEC) Market Will Continue to Boom in t …
The Human Umbilical Vein Endothelial Cells (HUVEC) Market research study is a professional report with premium insights into the size of the business, current patterns, drivers, risks, potential outcomes, and major segments. The Industry Report forecasts the future growth of the market based on precise assumptions. Furthermore, based on input from industry experts, the report provides actionable insights into the Human Umbilical Vein Endothelial Cells (HUVEC) market's future growth to…
Vascular Endothelial Growth Factor (VEGF) Market is projected to expand at a CAG …
Growing significance of genomics and proteomics has been contributing to the growth of the global vascular endothelial growth factor (VEGF) market. The market was valued at US$ 195.4 Mn at the end of 2021 and is projected to expand at a CAGR of 10.7% over the forecast period (2022-2032), according to Persistence Market Research.
Tumor cells, keratinocytes, platelets, renal mesangial cells, and macrophages are among the cells that produce VEGF. VEGF's…
Cosmetic Peptide Synthesis Market is projected to expand at a CAGR of 10.7% over …
Growing significance of genomics and proteomics has been contributing to the growth of the global vascular endothelial growth factor (VEGF) market. The market was valued at US$ 195.4 Mn at the end of 2021 and is projected to expand at a CAGR of 10.7% over the forecast period (2022-2032), according to Persistence Market Research.
Tumor cells, keratinocytes, platelets, renal mesangial cells, and macrophages are among the cells that produce VEGF. VEGF's…
Endothelial Cells Latest Trends and Forecast Analysis up to 2031
250 Pages Endothelial Cells Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider
Subtitle –Fact MR analysis of Endothelial Cells market provides compelling insights into the factors propelling sales prospects in key segments. It provides an executive-level blueprint of key market players' strategies and analyses their impact on overall growth projections.
According to Fact MR’s recent market research, Endothelial Cells sales to swell at propelled CAGR through 2031, as…
